Alkem Laboratories informs about updates
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (SEBI LODR Regulations) and in furtherance to earlier intimation dated 10th December 2025, captioned ‘GMP Inspection by Malta Medicines Authority at Alkem’s manufacturing facility located at Daman, India’, Alkem Laboratories has informed that the Company has received a ‘Certificate of GMP Compliance of a Manufacturer’ from the Malta Medicines Authority with respect to the Company’s manufacturing facility located at Daman, India. The said certificate is valid for a period of 3 years from the date of inspection being 09th December, 2025. A copy of this disclosure will be made available on the Company’s website in accordance with Regulation 30(8) of the SEBI LODR Regulations.
The above information is a part of company’s filings submitted to BSE.
